Navigation Links
Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
Date:7/23/2008

Company Focused on IND-Enabling Work with Protein Therapeutics that

Modulate Alternative Pathway of Complement System

CAMBRIDGE, Mass., July 23 /PRNewswire/ -- Taligen Therapeutics Inc. today announced it has initiated a corporate growth plan with the appointment of Abbie Celniker, Ph.D., as chief executive officer and the establishment of its headquarters in Cambridge, Mass. Dr. Celniker succeeds Woodruff Emlen, M.D., a co-founder of the company who remains president.

Under Dr. Celniker's leadership, Taligen intends to build its late-stage research and development operations in Cambridge while maintaining in Denver its early discovery activities that are closely aligned with an international complement biology research network organized by Michael Holers, M.D., one of the company's founders.

"Abbie's expertise will be critical to the acceleration of our efforts to develop protein therapeutics that are designed to modulate the alternative pathway of the complement system," said Dr. Emlen. "We are currently focused on IND-enabling work with our therapeutic candidates. Moreover, we have advanced our programs to the point where Abbie's significant experience in devising and implementing strategies and building infrastructure for the development of biologics will enable us to realize the potential of our expertise in complement biology."

Prior to joining Taligen, Dr. Celniker was global head of Novartis Biologics, where she built and oversaw Novartis' strategy and infrastructure for the late-stage discovery and development of protein therapeutics. Before this, she held senior research and development leadership positions with Millennium Pharmaceuticals, Wyeth BioPharma (Genetics Institute) and Genentech. Dr. Celniker earned a Ph.D. in molecular biology from the University of Arizona and a B.A. in biology from the University of California, San Diego.

"We are excited to have attracted someone of Abbie's caliber to T
'/>"/>

SOURCE Taligen Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinsons Therapeutics
2. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
3. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
4. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
5. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
6. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
7. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
8. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
9. Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
10. Silence Therapeutics Announces Board Changes
11. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... LONDON, Nov. 20 Boston ...ced that it has received 510(k) clearance from the...rk approval to market its WallFlex® Fully Cov...nt esophageal strictures (obstructions) caused by ...le esophageal cancer. ,, (Photo: http://www....
(Date:11/20/2009)..., Pa., Nov. 20 In respo...tions why currently available medications designed...ed, ECRI Institute, an independent nonprofit organ... Finasteride for Prevention of Prostate Cancer fo...ew York Times article, " Drugs to Deter Some Canc...
(Date:11/20/2009)...Nov. 20 Soligenix, Inc. ...ny), formerly known as DOR BioPharma, Inc., a late... it has formed a consortium to develop thermostabl...y acting vaccines. Soligenix received a $9.4 milli...d Infectious Diseases (NIAID), a division of the N...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Instrumentation Laboratory Announces Passion 26 Results Award Winners 57753 1Instrumentation Laboratory Announces Passion 26 Results Award Winners 57753 2Instrumentation Laboratory Announces Passion 26 Results Award Winners 57753 3Instrumentation Laboratory Announces Passion 26 Results Award Winners 57753 4Death Panel Inventor 26 Critic of Healthcare Reform Betsy McCaughey Has Close Ties to Philip Morris 3B Healthcare Industry Today Offers Complete Cove 57751 1Death Panel Inventor 26 Critic of Healthcare Reform Betsy McCaughey Has Close Ties to Philip Morris 3B Healthcare Industry Today Offers Complete Cove 57751 2Merrimack Pharmaceuticals Names Clet Niyikiza Ph D Senior Vice President Development 14175 1Merrimack Pharmaceuticals Names Clet Niyikiza Ph D Senior Vice President Development 14175 2
(Date:11/20/2009)... , CHICAGO, Nov. 20 ...the U.S. Food and Drug Administration (FDA) to est...ning chemicals. ,, Citing concern about the sa...ered without the benefit of professional consultat...aid that the application of chemically based tooth...
(Date:11/20/2009)... , WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USN...is on a mission to redefine what it means to be "h...nal counselor with a specialty in family counselin...e Forest University, Gladding says research shows ...ds to sadness and even depression during the holid...
(Date:11/20/2009)...editorial published online November 20 in the Jou...he exaggerated fears and hopes that often appear i...provides guidance for both the media and journals ...z, M.D., M.S., and Steven Woloshin, M.D., M.S., of...h Institute for Health Policy and Clinical Practic...
(Date:11/20/2009)...attle, Washington) November 20, 2009Emergency medi...ssess an estimated 350,000 cardiac arrests each ye...n cardiac arrest survive. Better quality cardiopu...l EMS providers may be associated with better pati...m (ROC) is the largest clinical research network t...
(Date:11/20/2009)...mers save up to one-third buying 90-day supply, st... News) -- Buying a three-month supply of prescript... one-month supply, according to a new study. , ...led for 395 drugs between 2000 and 2005, and found...tead of a one-month supply saved an average 29 per...
Breaking Medicine News(10 mins):Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Three-Month Supply Lowers Drug Costs 2
... field of genetics has been undergoing a revolutio...c mechanisms underlying common disorders and a hug...cific genetic disorders. // This has not onl...breakthrough has been the successful attempts of t...
...hlear implants for ears, which are done in a minim...e following the traditional way. Researchers from ...sent this research finding // at the 109th Annual ... scalp flap, mastoidectomy (a surgical removal of ...
... investigations suggest that treating the problem ...ren join school, can go a long way in curing the c...me out in the latest // edition of BMJ. About...cessary, but evidence to support this is currently...
...earchers from the University of Texas, M.D. Anders... on mutation or damage leads to development of col...efect in this gene leads to // development of colo...ancer. The study was conducted in 95 colorec...
...ox is a wrinkle control cream and a potent neuroto...wrinkles. The product is derived form a bacteria, ...// It is really surprising to note that this ...nction, minute changes that underlie memory and le...
...ing to counter the threat posed by new virus-induc...s, a city-based institute has launched a course of... Institute of // Biotechnology and Bioinformatics ...course is intended to provide qualified virologist...
Other Medicine News:Health News:Launch Of India’s First Virology Course At Pun 2
...th the OLA2500 High Speed Sorter (HSS) system, ded...ements. As a front-end sample-processor, the OLA25...ample tubes to their destination racks quickly to...rrors. Post-analytical archiving to any archive ra...
COCOON Disposable Paediatric - Neonatal / Child
Bair Hugger® Model 536 - Pediatric Blanket Short
CareQuilt® Pediatric Warming Blanket
Medicine Products: